FineHeart winner of the prestigious EIC Accelerator program
We were among the few companies selected by the European Innovation Council’s EIC Accelerator program that aims to help the most promising startups and SMEs to deploy disruptive innovations on the market. This takes the form first of a grant for €2.5 million.
This funding is expected to be followed by an equity investment by the EIC Fund of up to €15 million in the company’s Series C financing round.
This program, which aims to act as a catalyst to attract private investors to high-potential companies, is part of the European Union’s €95 billion Horizon Europe framework program for research and innovation. FineHeart is one of 13 French companies, and the only Medtech, to have been awarded a grant at the latest session of this competition which rewarded 75 European companies out of more than 1000 candidates.